{"pmid": "9933852", "sentences": {"sent_1": {"Section": "METHODS", "text": "Erythropoiesis after therapy with recombinant human erythropoietin : a dose-response study in anemic cancer surgery patients .", "entities": {"entity_1": {"text": "Erythropoiesis", "class": "Outcome", "negation": 0, "UMLS": "", "start": 0}, "entity_2": {"text": "recombinant human erythropoietin", "class": "Intervention", "negation": 0, "UMLS": "", "start": 4}, "entity_3": {"text": "anemic cancer surgery", "class": "Participant", "negation": 0, "UMLS": "", "start": 12}}, "relations": {}}, "sent_2": {"Section": "METHODS", "text": "BACKGROUND AND OBJECTIVES Preoperative treatment with 600 U/kg of recombinant human erythropoietin ( r-HuEPO ) effectively increases erythropoiesis in cancer patients .", "entities": {}, "relations": {}}, "sent_3": {"Section": "METHODS", "text": "The aim of this study was to evaluate the erythropoietic response after different doses of r-HuEPO in order to find the minimum effective dose .", "entities": {"entity_4": {"text": "erythropoietic response", "class": "Outcome", "negation": 0, "UMLS": "", "start": 9}, "entity_5": {"text": "doses of r-HuEPO", "class": "Intervention", "negation": 0, "UMLS": "", "start": 13}, "entity_6": {"text": "minimum effective dose", "class": "Outcome", "negation": 0, "UMLS": "", "start": 21}}, "relations": {}}, "sent_4": {"Section": "METHODS", "text": "MATERIALS AND METHODS Twenty anemic sideropenic patients ( hemoglobin < /=110 g/l ; serum iron < 600 microg/l ) with cancer of the gastrointestinal tract were randomly allocated to two", "entities": {"entity_7": {"text": "anemic sideropenic", "class": "Participant", "negation": 0, "UMLS": "", "start": 4}, "entity_8": {"text": "hemoglobin", "class": "Participant", "negation": 0, "UMLS": "", "start": 8}, "attribute_1": {"text": "< /=110 g/l ; serum iron", "class": "measure", "negation": 0, "UMLS": "", "start": 9}, "entity_9": {"text": "600 microg/l", "class": "Participant", "negation": 0, "UMLS": "", "start": 16}, "attribute_2": {"text": ") with cancer of the", "class": "measure", "negation": 0, "UMLS": "", "start": 18}, "entity_10": {"text": "were randomly allocated to two", "class": "Participant", "negation": 0, "UMLS": "", "start": 25}}, "relations": {}}, "sent_5": {"Section": "METHODS", "text": "groups : the first ( n = 10 ) received 400 U/kg of r-Hu EPO divided in 4 doses ( 100 U/kg each , every 4 days ) ; the", "entities": {"attribute_3": {"text": "400 U/kg of r-Hu", "class": "measure", "negation": 0, "UMLS": "", "start": 10}, "entity_11": {"text": "divided in", "class": "Intervention", "negation": 0, "UMLS": "", "start": 15}, "attribute_4": {"text": "each , every 4", "class": "measure", "negation": 0, "UMLS": "", "start": 22}}, "relations": {}}, "sent_6": {"Section": "METHODS", "text": "second ( n = 10 ) received 200 U/kg of r-HuEPO ( 50 U/kg each , every 4 days ) .", "entities": {"attribute_5": {"text": "200 U/kg of r-HuEPO", "class": "measure", "negation": 0, "UMLS": "", "start": 7}, "entity_12": {"text": "50", "class": "Intervention", "negation": 0, "UMLS": "", "start": 12}, "attribute_6": {"text": "each , every 4", "class": "measure", "negation": 0, "UMLS": "", "start": 14}}, "relations": {}}, "sent_7": {"Section": "METHODS", "text": "Both groups were given intravenous iron gluconate ( 125 mg ) every day for 15 days .", "entities": {}, "relations": {}}, "sent_8": {"Section": "METHODS", "text": "RESULTS After treatment , the serum iron level significantly rose in both groups .", "entities": {"entity_13": {"text": "serum iron level", "class": "Outcome", "negation": 0, "UMLS": "", "start": 5}, "attribute_7": {"text": "significantly rose", "class": "modifier", "negation": 0, "UMLS": "", "start": 8}}, "relations": {}}, "sent_9": {"Section": "METHODS", "text": "The production of new red blood cells was 176.3+/-90.8 ml in the 200 U/kg group and 268.4+/-79.4 ml in the 400 U/kg group ( p = 0.036 ) .", "entities": {"entity_14": {"text": "production of new red blood cells", "class": "Outcome", "negation": 0, "UMLS": "", "start": 1}, "attribute_8": {"text": "176.3+/-90.8 ml", "class": "measure", "negation": 0, "UMLS": "", "start": 8}, "entity_15": {"text": "200 U/kg group and 268.4+/-79.4", "class": "Intervention", "negation": 0, "UMLS": "", "start": 12}, "attribute_9": {"text": "in the", "class": "measure", "negation": 0, "UMLS": "", "start": 18}, "entity_16": {"text": "group ( p = 0.036", "class": "Intervention", "negation": 0, "UMLS": "", "start": 22}, "attribute_10": {"text": ".", "class": "measure", "negation": 0, "UMLS": "", "start": 28}}, "relations": {}}, "sent_10": {"Section": "METHODS", "text": "The increase of hemoglobin was significantly higher in the 400 U/kg group ( 22.3+/-2.0 g/l ) than in the 200 U/kg group ( 14.1+/-2.7 g/l ) ( p = 0.017", "entities": {"entity_17": {"text": "increase of hemoglobin", "class": "Outcome", "negation": 0, "UMLS": "", "start": 1}, "attribute_11": {"text": "higher", "class": "modifier", "negation": 0, "UMLS": "", "start": 6}, "entity_18": {"text": "400 U/kg group ( 22.3+/-2.0", "class": "Intervention", "negation": 0, "UMLS": "", "start": 9}, "attribute_12": {"text": ") than in the 200 U/kg", "class": "measure", "negation": 0, "UMLS": "", "start": 15}, "entity_19": {"text": ") ( p = 0.017", "class": "Intervention", "negation": 0, "UMLS": "", "start": 25}}, "relations": {}}, "sent_11": {"Section": "METHODS", "text": ") .", "entities": {}, "relations": {}}, "sent_12": {"Section": "METHODS", "text": "CONCLUSION The r-HuEPO dose of 400 U/kg appears significantly more effective than the 200 U/kg to stimulate erythropoiesis in anemic sideropenic cancer patients .", "entities": {"entity_20": {"text": "r-HuEPO dose", "class": "Intervention", "negation": 0, "UMLS": "", "start": 2}, "attribute_13": {"text": "400 U/kg appears significantly", "class": "measure", "negation": 0, "UMLS": "", "start": 5}, "attribute_14": {"text": "effective than the", "class": "modifier", "negation": 0, "UMLS": "", "start": 10}, "entity_21": {"text": "to stimulate erythropoiesis in", "class": "Intervention", "negation": 0, "UMLS": "", "start": 15}, "attribute_15": {"text": "sideropenic", "class": "modifier", "negation": 0, "UMLS": "", "start": 20}, "entity_22": {"text": "cancer", "class": "Outcome", "negation": 0, "UMLS": "", "start": 21}, "entity_23": {"text": ".", "class": "Participant", "negation": 0, "UMLS": "", "start": 23}}, "relations": {}}}}